Clinical Trials Directory

Trials / Completed

CompletedNCT02772653

Evaluation of Resuscitation Markers in Trauma Patients

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Andrea Campos-Serra · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Severe trauma patients have an elevated risk of multiple organ failure and death. In order to increase survival possibilities the initial treatment must be focused into resuscitation from shock. Traditionally the most common resuscitation markers used are vital signs and urine output. Unfortunately, many patients might present normal vital signs, but still undergo a compensated shock with persistent acidosis, hence being able to develop multiple organ failure and death. Consequently, it is important to define better resuscitation markers for these patients. This investigation project consists in an observational prospective study, performed by a multidisciplinary team, in which different resuscitation markers are evaluated in severe trauma patients. There will be a specific timing (1st, 8th and 24th hours from arrival) evaluation of different markers: hemodynamic (vital signs, urine output, etc); analytical (lactate, base excess, natriuretic atrial peptide); tissue perfusion markers (NIRS); microcirculation markers (videomicroscopy) and coagulopathy markers (thromboelastometry). There will be a registry of total volume administration; blood cell transfusions and vasoactive drug requirements. Each marker will be evaluated in relation to mortality; multiple organ failure; massive transfusion protocol activation; blood cell transfusion requirement; surgical control of bleeding requirement and emergent arteriographic embolization. The objective of this study is to demonstrate which of these markers is better to predict hemodynamic evolution of severe trauma patients and might become a guide for resuscitation in the future.

Conditions

Interventions

TypeNameDescription
OTHERBlood LactateAnalyzed at the 1rst, 8th and 24th hour from hospital admission
OTHERBlood Base ExcessAnalyzed at the 1rst, 8th and 24th hour from hospital admission
OTHERBlood B-type Natriuretic PeptideAnalyzed at the 1rst, 8th and 24th hour from hospital admission
OTHERBlood Thromboelastometry (ROTEM)Analyzed at the 1rst, 8th and 24th hour from hospital admission
OTHERNear-infrared spectroscopyAnalyzed at the 1rst, 8th and 24th hour from hospital admission
OTHERSublingual videomicroscopyAnalyzed at the 1rst, 8th and 24th hour from hospital admission

Timeline

Start date
2016-05-01
Primary completion
2019-03-26
Completion
2019-03-26
First posted
2016-05-13
Last updated
2019-05-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02772653. Inclusion in this directory is not an endorsement.